GlobalData on MSN2d
SCG’s HBV T-cell therapy shows promise in Phase I trial
SCG has revealed late-breaking data outcomes from the Phase I clinical trial of autologous hepatitis B virus (HBV)-specific T ...
Latrobe Valley Express2d
MCG to SCG for breast cancer research
The inspiring trek is for the McGrath Foundation as an initiative to raise awareness and money for breast cancer research, ...
Abbott consoled during emotional SCG tribute Phillip Hughes
Ten years to the day since the 25-year-old’s death, players stand for a minute’s silence before play at the SCG.
Brave Abbott’s superb spell after breaking down in emotional SCG tribute to Hughes
NSW fast bowler Sean Abbott overcame strong emotions on the 10-year anniversary of Phillip Hughes’ death to deliver a ...
Phillip Hughes: Touching tribute at SCG to commemorate 10 years since cricketer’s death
Players, umpires and staff have paid tribute to Phillip Hughes on the 10th anniversary of his death at the SCG, as his family ...
‘Incredibly brave’: Abbott consoled during emotional SCG tribute to Phillip Hughes
Ten years to the day since the 25-year-old’s death, players stand for a minute’s silence before play at the SCG.
Sporting News on MSN4h
'Ashes of boxing' on the radar as boxing powerbroker Eddie Hearn reveals plan to dominate Australia
Australian boxing fans could be set for a bumper 2025, with the sport’s biggest promoter lining up a raid on the market, ...
SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024
SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data ...
Oh my, forgotten golf star roars to life at the Open
Su Oh has credited her esteemed new coach for helping send the one-time child prodigy rocketing to a share of the Australian ...
Yahoo Finance2d
SCG’s HBV T-cell therapy shows promise in Phase I trial
SCG has revealed late-breaking data outcomes from the Phase I clinical trial of autologous hepatitis B virus (HBV)-specific T-cell receptor-engineered T Cell (TCR-T) therapy, SCG101. The therapy ...
Morningstar3d
SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024
SINGAPORE, Nov. 25, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and ...